WILMA BALIEM: Open Payments
NPI 1871706978 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,107 in 137 payments from 36 companies in 2025. Trend: 2023 $3,255 · 2024 $2,966 · 2025 $3,107
Food & beverage: $2,982Education: $124
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $392 |
| Daiichi Sankyo Inc. | 12 | $369 |
| Janssen Biotech, Inc. | 17 | $249 |
| Pharmacosmos Therapeutics Inc. | 4 | $174 |
| Novartis Pharmaceuticals Corporation | 10 | $171 |
| AstraZeneca Pharmaceuticals LP | 9 | $161 |
| Regeneron Healthcare Solutions, Inc. | 7 | $152 |
| PFIZER INC. | 7 | $146 |
| Celgene Corporation | 4 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $94 |
Products named: Enhertu, LIBTAYO, ERLEADA, Zynyz, COSELA, REBLOZYL, Monjuvi, BESREMI.
Industry payments across AL — which companies pay providers there.
